Attached files

file filename
EX-10.7 - EX-10.7 - ASSEMBLY BIOSCIENCES, INC.asmb-ex107_183.htm
EX-32.2 - EX-32.2 - ASSEMBLY BIOSCIENCES, INC.asmb-ex322_7.htm
EX-32.1 - EX-32.1 - ASSEMBLY BIOSCIENCES, INC.asmb-ex321_6.htm
EX-31.2 - EX-31.2 - ASSEMBLY BIOSCIENCES, INC.asmb-ex312_8.htm
EX-31.1 - EX-31.1 - ASSEMBLY BIOSCIENCES, INC.asmb-ex311_9.htm
EX-21.1 - EX-21.1 - ASSEMBLY BIOSCIENCES, INC.asmb-ex211_11.htm
EX-4.3 - EX-4.3 - ASSEMBLY BIOSCIENCES, INC.asmb-ex43_426.htm
10-K - 10-K - ASSEMBLY BIOSCIENCES, INC.asmb-10k_20191231.htm

 

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

(1)

Registration Statement (Form S-3 No. 333-222366) of Assembly Biosciences, Inc.,

 

(2)

Registration Statement (Form S-8 No. 333-173613) pertaining to the 2007 Stock Incentive Plan and 2010 Equity Incentive Plan of Ventrus Biosciences, Inc.,

 

(3)

Registration Statement (Form S-8 No. 333-182167) pertaining to the 2010 Equity Incentive Plan of Ventrus Biosciences, Inc.,

 

(4)

Registration Statement (Form S-8 No. 333-198803) pertaining to the 2014 Stock Incentive Plan of Assembly Biosciences, Inc.,

 

(5)

Registration Statement (Form S-8 No. 333-213019) pertaining to the Amended and Restated 2014 Stock Incentive Plan of Assembly Biosciences, Inc.,

 

(6)

Registration Statement (Form S-8 No. 333-216902) pertaining to the Non-Qualified Stock Option Agreements dated May 16, 2014 of Assembly Biosciences, Inc.,

 

(7)

Registration Statement (Form S-8 No. 333-219919) pertaining to the 2017 Inducement Award Plan of Assembly Biosciences, Inc.,

 

(8)

Registration Statement (Form S-8 No. 333-226703) pertaining to the 2018 Stock Incentive Plan and the 2018 Employee Stock Purchase Plan of Assembly Biosciences, Inc.,

 

(9)

Registration Statement (Form S-8 No. 333-233030) pertaining to the 2018 Stock Incentive Plan of Assembly Biosciences, Inc., and

 

(10)

Registration Statement (Form S-8 No. 333-234580) pertaining to 2019 Inducement Award Plan and the Amended and Restated 2014 Stock Incentive Plan of Assembly Biosciences, Inc.

of our reports dated March 4, 2020, with respect to the consolidated financial statements of Assembly Biosciences, Inc. and the effectiveness of internal control over financial reporting of Assembly Biosciences, Inc. included in this Annual Report (Form 10-K) of Assembly Biosciences, Inc. for the year ended December 31, 2019.

/s/ Ernst & Young LLP

Redwood City, California

March 4, 2020